Stay updated with breaking news from Patrick Wen. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Treatment with dabrafenib and trametinib yielded encouraging rate of durable responses in both high-grade and low-grade brain tumors carrying the rare
According to a clinical trial report, the combination of two targeted cancer drugs showed unprecedented, “clinically meaningful” activity in patients with highly malignant brain tumors that carried a rare genetic mutation.
A combination of two targeted cancer drugs showed unprecedented, “clinically meaningful” activity in patients with highly malignant brain tumors that
Chimerix Acquires Oncoceutics to Expand Pipeline with Late-Stage Oncology Program January 08, 2021 06:00 ET | Source: Chimerix, Inc. Chimerix, Inc. ONC201 Registrational Trial for Recurrent H3 K27M-mutant Glioma Compelling Response Rates to Date; Defined Regulatory Path to Registration Pivotal Data Anticipated in 2021 to Support Potential Registration, Addressing an Estimated Market Opportunity of Greater than $500 Million Management to Host Conference Call at 8:30 a.m. ET Today DURHAM, N.C., Jan. 08, 2021 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX), a biopharmaceu...